Skip to main content
. 2020 Jun 26;29:100563. doi: 10.1016/j.ijcha.2020.100563

Table 3.

Cox proportional hazards regression analyses for cardiovascular outcome within 1500 days follow-up.

Univariable Regression
Multivariable Regression
Model 1 (I-PRESERVE)
Model 2
Variable HR 95% CI P value HR 95% CI P value HR 95% CI P value
Age (years) 1.01 1.00–1.03 0.031 1.01 0.99–1.02 0.075 1.00 0.99–1.02 0.433
Male sex (yes) 0.90 0.73–1.17 0.453
BMI (kg/m2) 0.96 0.93–1.00 0.091
Previous hospitalization for HF (yes) 1.62 1.19–2.21 0.002 1.42 1.02–1.99 0.036 1.47 0.97–2.24 0.068
NYHA III or IV (yes) 1.80 1.33–2.43 <0.001 1.16 0.78–1.73 0.453
Diabetes mellitus (yes) 1.14 0.87–1.49 0.327 1.26 0.96–1.66 0.94
Hypertension (yes) 0.77 0.57–1.03 0.083
Dyslipidemia (yes) 0.99 0.72–1.36 0.977
IHD (yes) 1.04 0.80–1.34 0.740
Atrial fibrillation (yes) 1.18 0.89–1.59 0.237
SBP (mm Hg) 1.00 0.99–1.00 0.877
DBP (mm Hg) 0.99 0.98–1.00 0.126
Hemoglobin (g/dL) 0.87 0.81–0.93 <0.001 0.90 0.83–0.99 0.033
hs-CRP (mg/L) 1.02 0.97–1.07 0.422
eGFR (mL/min/1.73 m2) 1.00 0.97–1.01 0.351
ln-BNP 1.16 1.05–1.28 0.003 1.08 0.96–1.20 0.160 1.01 0.88–1.16 0.823
LVEF (%) 0.99 0.97–1.01 0.552
SVI (L/min) 0.99 0.98–1.00 0.555
LAD (mm) 1.01 1.00–1.03 0.047 1.00 0.98–1.02 0.690
E/e′ 1.02 0.99–1.04 0.082
TR-PG (mm Hg) 1.01 0.99–1.03 0.124
PAP (mm Hg) 1.01 1.00–1.03 0.018 1.01 0.95–1.02 0.175
Diuretics (yes) 1.48 1.12–1.95 0.005 1.09 0.75–1.59 0.629
ACE-I or ARB (yes) 1.07 0.82–1.40 0.578
CCB (yes) 0.90 0.69–1.16 0.437
Beta-blocker (yes) 0.96 0.74–1.24 0.792
Statin (yes) 1.05 0.80–1.38 0.714
CONUT score 1.16 1.08–1.24 <0.001 1.14 1.06–1.22 <0.001 1.12 103–1.21 0.005

Model 1: age, previous hospitalization for HF, diabetes mellitus, ln-BNP and CONUT score.

Model 2: variables of statistical significance in the univariable analyses (P < 0.05).

Abbreviations as shown in this table. HR: hazard ratio CI: confidence interval ln-BNP: natural logarithmic transformed B-type natriuretic peptide level